Predicting the risk of type 2 diabetes: when does the clock start ticking?

Citation metadata

Date: Mar. 2010
From: Consultant
Publisher: HMP Communications, LLC
Document Type: Report
Length: 582 words
Lexile Measure: 1280L

Document controls

Main content

Article Preview :

American medicine is undergoing the greatest financial scrutiny in its history. The hue and cry for reform stems primarily from the soaring costs of health care. However, placing the blame for these costs solely on increased utilization of technology, cutting-edge pharmaceuticals, cost-shifting hospitals, and physicians misses a bigger mark.


Let's look at a relatively expensive and prevalent disease, type 2 diabetes mellitus. Pelletier and colleagues (1) assessed the costs of this disease and its multiple complications. Myocardial infarction, heart failure, and renal disease occurred in 7.2%, 14.0%, and 11.0%, respectively, of a large but typical cohort of patients with type 2 diabetes. The 12-month mean cost per patient who experienced each complication was $41,695, $30,066, and $34,987.

The population burdened with type 2 diabetes is on the rise, as are these and other expensive complications (including...

Source Citation

Source Citation   

Gale Document Number: GALE|A221434261